Sign inJoin waitlistJoin the waitlist

Myron Bednar

Physician · Hunterdon Hematology Oncology, LLC

Credentials: · · · · ·

History

Hunterdon Hematology Oncology, LLC
Present

Mount Sinai Medical Center; Medical Oncology & Hematology
1996–1998
Mount Sinai Medical Center; Medical Oncology & Hematology
1993–1996
Robert Wood Johnson Medical School
1989–1993
Emory University

Research

A Phase I/II study of weekly paclitaxel and 3 days of high dose oral estramustine in patients with hormone-refractory prostate carcinoma
Cancer · 2001 · 23 citations
13-cis retinoic acid and complete androgen blockade in advanced hormone-naive prostate cancer patients: report of a phase II randomized study
Journal of Clinical Oncology · 2002 · 12 citations
Manifestations of superwarfarin ingestion: a plea to increase awareness
Letter or commentary · American Journal of Hematology · 2010 · 3 citations

Anna Ferrari
2 papers
Harvinder Singh
2 papers
Abraham Chachoua
1 paper
CC
Caroline Cromwell
1 paper
Dipika Misra
1 paper · 1 as a fellow
FM
Franco Muggia
1 paper
IE
Isaac Esseesse
1 paper
LA
Louis Aledort
1 paper
NS
Nelson Stone
1 paper
Richard Stock
1 paper
Samir Taneja
1 paper

Clinical trials

Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial
Site PI · Recruiting · Phase 2
National Cancer Institute (NCI)
2025–2027
E-Mindfulness Approaches for Living After Breast Cancer
Site PI · Recruiting · Phase 3
NRG Oncology
2025–2030
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
Site PI · Recruiting · Phase 3
BriaCell Therapeutics Corporation
2023–2028
A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab
Site PI · Recruiting · Phase 3
National Cancer Institute (NCI)
2023–2031